16:02 Dec 20
Eris Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Eris Lifesciences Ltd.
43/100 Medium Financial Strength
Quality23/100 Expensive Valuation
Valuation59/100 Technically Neutral
TechnicalSWOT
Strength
5
Weakness
7
Opportunity
0
Threat
0
18.79K
Market Cap (Cr)
53.92
PE Ratio
6.78
Price to Book Ratio
42.17
RSI
19.50 %
Net Profit Margin
Rating Based on 3 Analysts
Buy
100%
Hold
0%
Sell
0%
Buy
Analyst Price Target
The average price target is 1452.33 with a high estimate of 1648 and low estimate of 1100
Current 1380.30
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
